نيو إنغلاند جورنال أوف ميديسين
An editorial in "The New England Journal of Medicine" suggested that while NECC appeared to be in clear violation of existing FDA policy the 2002 Supreme Court decision may have weakened federal-state cooperation. The "NEJM" noted: